Discover the full record of transactions filed by 方国良, Directeur Exécutif. Director active across 1 company, notably 沃森生物. Cumulatively, 10 reports have been recorded. Regulator: SSE / SZSE (CSRC). The full history is openly available.
Companies and markets linked to 方国良
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Fang Guoliang is an Executive Director at Watson Bio. He plays a key role in the strategic direction of the company, focusing on innovation in the biopharmaceutical sector. His expertise is essential for developing new products.